Differences in Tissue and Species Tropism of Reptarenavirus Species Studied by Vesicular Stomatitis Virus Pseudotypes by Korzyukov, Yegor et al.
viruses
Article
Differences in Tissue and Species Tropism of
Reptarenavirus Species Studied by Vesicular
Stomatitis Virus Pseudotypes
Yegor Korzyukov 1, Rommel Iheozor-Ejiofor 1, Lev Levanov 1, Teemu Smura 1, Udo Hetzel 2,3 ,
Leonora Szirovicza 1 , Juan Carlos de la Torre 4 , Luis Martinez-Sobrido 5 , Anja Kipar 2,3 ,
Olli Vapalahti 1,3,6 and Jussi Hepojoki 1,2,*
1 Medicum, Department of Virology, University of Helsinki, 00100 Helsinki, Finland;
yegor.korzyukov@helsinki.fi (Y.K.); rommel.iheozor-ejiofor@helsinki.fi (R.I.-E.); lev.levanov@helsinki.fi (L.L.);
teemu.smura@helsinki.fi (T.S.); leonora.szirovicza@helsinki.fi (L.S.); olli.vapalahti@helsinki.fi (O.V.)
2 Vetsuisse Faculty, Institute of Veterinary Pathology, University of Zürich, 8006 Zürich, Switzerland;
udo.hetzel@uzh.ch (U.H.); anja.kipar@uzh.ch (A.K.)
3 Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki,
00100 Helsinki, Finland
4 Department of Immunology and Microbial Science IMM-6, The Scripps Research Institute, La Jolla,
CA 92037, USA; juanct@scripps.edu
5 Texas Biomedical Research Institute, San Antonio, TX 78227, USA; lmartinez@txbiomed.org
6 Department of Virology, Helsinki University Hospital, University of Helsinki, 00100 Helsinki, Finland
* Correspondence: jussi.hepojoki@helsinki.fi or jussi.hepojoki@uzh.ch;
Tel.: +358-29-412-6608 & +358-50-448-2866
Received: 4 March 2020; Accepted: 31 March 2020; Published: 2 April 2020


Abstract: Reptarenaviruses cause Boid Inclusion Body Disease (BIBD), and co-infections by several
reptarenaviruses are common in affected snakes. Reptarenaviruses have only been found in captive
snakes, and their reservoir hosts remain unknown. In affected animals, reptarenaviruses appear
to replicate in most cell types, but their complete host range, as well as tissue and cell tropism are
unknown. As with other enveloped viruses, the glycoproteins (GPs) present on the virion’s surface
mediate reptarenavirus cell entry, and therefore, the GPs play a critical role in the virus cell and tissue
tropism. Herein, we employed single cycle replication, GP deficient, recombinant vesicular stomatitis
virus (VSV) expressing the enhanced green fluorescent protein (scrVSV∆G-eGFP) pseudotyped
with different reptarenavirus GPs to study the virus cell tropism. We found that scrVSV∆G-eGFPs
pseudotyped with reptarenavirus GPs readily entered mammalian cell lines, and some mammalian
cell lines exhibited higher, compared to snake cell lines, susceptibility to reptarenavirus GP-mediated
infection. Mammarenavirus GPs used as controls also mediated efficient entry into several snake cell
lines. Our results confirm an important role of the virus surface GP in reptarenavirus cell tropism and
that mamma-and reptarenaviruses exhibit high cross-species transmission potential.
Keywords: BIBD; reptarenavirus; arenavirus; VSV; pseudotype; tissue tropism
1. Introduction
Viral zoonoses can have severe consequences on human health as illustrated by viral hemorrhagic
fevers (VHFs) caused by filo-, flavi-, hanta-, nairo-, and arenaviruses [1–7]. These viruses cause
long-term, usually subclinical, chronic infections in their natural host reservoirs [8]. However,
upon zoonotic transmission, these viruses can cause severe disease in humans via different
mechanisms [4,9,10].
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Boid Inclusion Body Disease (BIBD), initially recognized in the 1970s, affects mainly captive boas
and pythons [11]. BIBD is characterized by the formation of electron dense intracytoplasmic inclusion
bodies (IB) [12] in various cell types (including blood cells) and tissues [13–15]. BIBD spreads efficiently
within collections, and the recommendation to euthanize snakes with BIBD can lead to loss of entire
collections [11]. Clinical manifestations of BIBD are variable and include central nervous system (CNS)
signs such as head tremors, loss of coordination, and regurgitation [11]. Death due to secondary
bacterial, fungal or protozoal infections and neoplastic diseases is common in snakes with BIBD [16],
suggesting that BIBD might be associated with an impaired immune response.
The causative agent for BIBD remained unknown until the early 2010s, when novel arenaviruses
were identified in snakes with BIBD [13,15,17], which extended arenaviruses host range to species
other than the well-established rodent reservoirs [1–3]. These findings led to establishment of two
genera, Mammarenavirus and Reptarenavirus, within the family Arenaviridae [18,19]. We and others
have documented that snakes with BIBD are often co-infected with several reptarenaviruses [20,21],
and we discovered another novel arenavirus in snakes, Haartman Institute Snake virus-1 (HISV-1) [20],
which later became the type species of a third arenavirus genus, Hartmanivirus [19,22]. The finding that
IBs contain reptarenavirus NP further supported the link between reptarenavirus infection and BIBD [15].
Experimental infection of boas and pythons with purified reptarenaviruses provided unequivocal
evidence that reptarenaviruses can cause BIBD [14]. Interestingly, in this experiment, pythons developed
strong CNS signs without evidence of IB formation, whereas seemingly healthy boas harbored large
IBs in most tissues [14]. Moreover, we have documented vertical transmission of reptarenaviruses and
hartmaniviruses in boas, and the swarm of reptarenavirus genome segments transmitted can vary
between the offspring [23]. The origins and reservoir hosts of both reptarenaviruses and hartmaniviruses
remain unknown, as the viruses have only been found in captive snakes [13,15,17,24,25].
Arenaviruses have a negative-sense bi-segmented RNA genome, with the exception of members
of the most recently recognized arenavirus genus, Antennavirus, identified in fish, which have
a tri-segmented genome [19]. The large (L) genome segment encodes the RNA-dependent-RNA-
polymerase (RdRp) and the matrix-like Z protein (ZP) [26,27], but hartmaniviruses lack the ZP [22].
The small (S) segment encodes the glycoprotein precursor protein (GPC) and the NP [28–31].
The mammarenavirus GPC is initially cleaved by cellular signal peptidase [32] and later by subtilisin
kexin isozyme-1 (SKI-1)/site-1 protease (S1P) producing a stable signal peptide (SSP) and glycoproteins
GP1 and GP2 [33]. While reptarenavirus GPCs appear to lack the SSP, it exists in hartmanivirus
GPCs [22]. Furin, instead of SKI-1/S1P host cell protease, presumably mediates the secondary
processing of hartmanivirus GPC [22]. Trimers of the SSP-GP1-GP2 complex comprise the virion spike
of mammarenaviruses [34]. GP1 mediates binding to the cell surface receptor [35–38], and GP2 directs
the fusion with endosomal membranes [39,40]. SSP also participates in the fusion process [41,42].
GP1 binding to the cell surface receptor represents the first step of arenavirus entry into a new
host cell [35,38]. Accordingly, cell surface receptor expression pattern contributes to arenavirus cell
and tissue tropism [43]. The conserved and widely expressed receptor for extracellular matrix proteins,
α-dystroglycan (α-DG), is a main receptor for Old World (OW) mammarenaviruses, such as lymphocytic
choriomeningitis virus (LCMV) and Lassa virus (LASV) [38]. Secondary alternative receptors, including
members of the Tyro3/Axl/Mer and T-cell immunoglobulin mucin (TIM) receptor families may account
for LASV and LCMV infection of cells lacking fully glycosylated α-DG [44,45]. Cell entry of the
OW hemorrhagic fever (HF) mammarenavirus Lujo virus (LUJV) is mediated by neuropilin (NRP)-2,
a cell-surface receptor for semaphorins [46]. NRP-2 is highly expressed in microvascular endothelial
cells, which may contribute to LUJV-induced coagulopathy. The completion of the cell entry process
for LASV and LUJV involves a late endosomal receptor switch mechanism, the late endosomal resident
proteins LAMP and CD36 for LASV and LUJV, respectively [46,47]. Human transferrin receptor 1 (TfR1)
is the main cellular receptor used for cell entry of pathogenic New World (NW) mammarenaviruses,
including Junin virus (JUNV) and Machupo virus (MACV) [35].
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Hartmaniviruses appear to target neuronal and smooth muscle cells [22], while reptarenaviruses
infect a wide range of cell types [14,48]. Interestingly, snakes with BIBD often carry more L than
S segments [20,21,23], and the distribution of segments may vary between tissues of the same
individual [20,23]. The difficulties in obtaining isolated L and S segment pairs significantly hampers
the studies on the role of the GPs in reptarena-and hartmanivirus cell entry.
Here, we document the use of single cycle replication, GP deficient, recombinant vesicular stomatitis
virus (VSV) expressing the enhanced green fluorescent protein (scrVSV∆G-eGFP) pseudotyped with
arenavirus GPs to study reptarenavirus GP-mediated cell tropism. Our results show that reptarenavirus
GPs efficiently provide entry into a wide range of mammalian cell lines, and correspondingly
mammarenavirus GPs enable entry into culture reptilian cell lines, suggesting that arenaviruses could
possess a high cross-species transmission potential.
2. Materials and Methods
2.1. Cell Lines
We made use of the following mammalian cell lines: African green monkey kidney (Vero
E6, American Type Culture Collection, ATCC), human lung carcinoma (A549, ATCC), human
embryonic kidney (HEK293FT, Thermo Fisher Scientific, Waltham, MA, USA), human neuroblastoma
(SK-N-SH, ATCC), Chinese hamster ovary (CHO, ATCC), and baby hamster kidney (BHK-21, ATCC)
cells. We maintained the mammalian cells at standard conditions (5% CO2, 37 ◦C) in medium
supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU/mL penicillin, and 100
µg/mL streptomycin. We used minimal essential medium (MEM) for Vero E6 and A549, and Dulbecco’s
Modified Eagle Medium (DMEM) for the other cell lines. In addition, we used the following reptilian
cell lines: Boa constrictor kidney (I/1Ki, in MEM), lung (V/5Lu, DMEM), liver (V/1Liv), heart (V/2Hz,
DMEM), and brain (V/4Br, DMEM) cells, and Morelia viridis liver (VII/2Liv, DMEM) cells described
in [15,49,50]. We maintained the snake cells at 5% CO2 and 30 ◦C, and used collagen-coated (as
described [50]) bottles and plates for VII/2Liv and V/1Liv cells.
2.2. Phylogenetic Analysis
We retrieved the arenavirus amino acid sequences from GenBank and aligned them using INS-i
algorithm embedded in MAFFT version 7 [51]. The phylogenetic tree was inferred using the Bayesian
method implemented in MrBayes v3.1.2 [52] and the Blosum model of amino acid substitution. MrBayes
was run for a million generations and sampled every 5000 generations, with final standard deviation
of 0.005 between 2 runs.
2.3. Plasmids and Cloning
We selected the following arenavirus GPCs to be cloned into the pCAGGS-HA (pCAGGS-FLAG
for aurora borealis virus-1, ABV-1) vector [53]: University of Helsinki virus-1 (UHV-1, GenBank
accession no. KR870011.1), UHV-2 (KR870016.1), University of Giessen virus-1 (UGV-1, NC_039005.1),
ABV-1 (KR870010.1), ABV-2 (KR870018.1), Golden Gate virus-1 (GGV-1, NC_018483.1), CAS virus-1
(CASV-1, JQ717262.1), tavallinen suomalainen mies virus-2 (TSMV-2, KX527575), GPC from S5 segment
(S5-like, KX527579.1), Haartman Institute snake virus-1 (HISV, NC_043444.1), JUNV (NC_005081.1),
and LCMV (AY847350.1). The UHV-2, UGV-1, HISV-1, LCMV, and JUNV GPC constructs are
described in [50]. We used the following primers for RT-PCR amplification of ABV-1, ABV-2,
TSMV-2, and S5-like GPCs: ABV-1_FWD 5’-TTATGAGCTCATGGCGGGTCAGACTC-3´, ABV-1_REV
5´-ATAAC CCGGGCCTTCTCACCCAGC-3´, ABV-2_FWD 5´-TTATGAGCTCATGGCAGGCTGGGC-3´,
ABV-2_REV 5´-ATAAATGCATTCTTCTAACCCAACTGCACAC-3´, TSMV-2_FWD 5´-TTATGAG
CTCATGGCGGGCTGGAT-3´, TSMV-2_REV 5´-ATAACCCGGGCCTTCTCACCCAACTACAC-3´,
S5_FWD 5´-TTATGAATTCATGGCACCCACTCTGATG-3´, S5_REV 5´-ATAACCCGGGTCTCTT
GACCCAGCT -3´. The RT-PCR products were cloned into pCAGGS-HA expression plasmid
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as described [50]. We ordered the GPCs of CASV-1 and GGV-1 GPCs as synthetic genes from
GeneUniversal (Newark DE USA), subcloned them into pCAGGS-HA and produced plasmid maxipreps
as described [50]. We verified the inserts by Sanger sequencing (DNA Sequencing and Genomics
Laboratory, Institute of Biotechnology, University of Helsinki).
2.4. Expression of Arenavirus GPCs, Cell Surface Biotinylation, and Purification of Biotinylated Proteins
HEK293FT cells served to produce the pseudotypes bearing arenavirus GPs. We transfected
HEK293FT cells using FuGENE HD (Promega, Madison, WI, USA), plated the HEK293FT cells onto
12-well plates, allowed them to reach ~80% confluency, and replaced the medium (as above but with
5% FBS and without antibiotics) on the day of transfection. We prepared the reagent:DNA mixes
(4:1 ratio) by diluting the plasmid into 51 µL of OptiMEM (Sigma, Saint Louis, MO, USA) to yield
0.02 µg/µL, added 4.4 µL of Fugene HD, mixed by pipetting, allowed the complexes to form for 15 min
at room temperature (RT), added the mix onto the cell layers, and incubated the cells for 48 h.
To analyze the processing and trafficking of the expressed GPs to the cell surface, we washed the
transfected cells at 48 h post transfection three times with phosphate-buffered saline (PBS), and treated
the cells with EZ-Link Sulfo-NHS-SS-Biotin (ThermoFisher Scientific, Waltham, MA, USA) following
the manufacturer’s protocol. After the labelling reaction, we washed the cells three times with
Tris-buffered saline (TBS, pH 7.4), lysed the cells in 50 mM Tris, 150 mM NaCl, 1% Triton X-100, pH 8.0,
supplemented with EDTA-free protease inhibitor cocktail (Roche, Basel, Switzerland), and cleared
the lysate by centrifugation (5 min, 10,000× g). Pierce Monomeric Avidin Agarose (ThermoFisher
Scientifc, Waltham, MA, USA), used according to the manufacturer’s protocol, served to pull down the
biotinylated proteins. We eluted the bound protein to Laemmli sample buffer by boiling, and analyzed
the proteins as described under immunoblotting.
2.5. Generation of VSV Pseudotyped with Arenavirus GPs
To generate VSV pseudotypes, we inoculated the transfected cells at 48 h post transfection
with rVSV-∆G stock prepared as described [54]. Briefly, we added 300 µL/well (corresponding to a
multiplicity of infection of 3 to 5) of rVSV-∆G, incubated the cells for 1–1.5 h on an orbital shaker at
RT, removed the inoculum, added fresh medium (as above but with 5% FBS and without antibiotics),
and incubated the cells for 48 h. After 48 h infection (and 96 h after transfection), we collected the
cell culture supernatants, filtered them through a 0.45 µm filter (Millipore, Burlington, MA, USA),
and pelleted the viruses by ultracentrifugation (Beckman coulter [Brea, CA, USA] SW-55 rotor, 50,000× g,
4 ◦C, 1 h) using a 0.5 mL 20% (w/v) sucrose cushion. Pelleted viruses were resuspended in PBS by
gentle pipetting, and the aliquots were stored at 4 ◦C or −80 ◦C for further use.
2.6. Infections with Pseudotyped Viruses
We titrated the pseudovirus stocks and pelleted virions using V/2Hz cells grown on 96-well
plates. Briefly, we prepared a 10-fold dilution series (from 1:10 to 1:108) for each stock, added 10 µL
of diluted virus onto cells grown on 96-well plates, incubated (5% CO2, 30 ◦C) the plates for 48–60 h,
and enumerated the fluorescent focus forming units per ml (FFFUs/mL) using fluorescence microscopy.
For studying the cell tropism of the pseudotyped viruses in mammalian and reptilian cells,
we seeded the different cell lines onto 96-well plates and inoculated the cells with the pseudotyped
viruses diluted according to the initial titration on V/2Hz cells, aiming at approximately 250–500
FFFUs per well. We removed the scrVSV∆G-eGFP pseudovirus inocula after 2 h incubation, supplied
fresh medium, and incubated the cells (snake cells at 5% CO2 and 30 ◦C; mammalian cells at 5% CO2
and 37 ◦C) for 48–60 h. After the incubation, we fixed the cells with 4% paraformaldehyde (PFA;
pH 7.4) and stained the nuclei with Hoechst 33342. We used quadruplicates for each pseudotype,
and scrVSV∆G-eGFPs pseudotyped with VSV G and naked scrVSV∆G-eGFPs (i.e., the supernatant
collected from non-transfected cells inoculated with scrVSV∆G-eGFP pseudotyped with VSV G).
The Opera Phenix High Content Screening System (PerkinElmer, Waltham, MA, USA), provided by
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FIMM (Institute for Molecular Medicine Finland, High Content Imaging and Analysis [FIMM-HCA]),
served to enumerate the infected cells.
2.7. Immunoblotting
The bicinchoninic acid (BCA) protein assay kit (Pierce, Thermo Scientific, Waltham, MA, USA)
was employed to determine the protein concentrations of the cell lysates in 50 mM Tris, 150 mM
NaCl, 1% Triton X-100, pH 8.0, supplemented with EDTA-free protease inhibitor cocktail (Roche,
Basel, Switzerland). We used ready-made 4–20% Mini-PROTEAN® TGX (Bio-Rad, Hercules, CA,
USA) to separate the proteins (5 µg of total protein per lane for the lysates) and wet blotting to
transfer the proteins onto nitrocellulose membranes (GE Healthcare, Chicago, IL, USA) according
to standard protocols (https://www.gelifesciences.com/en/us/solutions/protein-research/knowledge-
center/western-blotting/comparison-of-transfer-methods-in-western-blotting) as described [55]. After
30 min blocking in 50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.4 (TBS-T) supplemented with 3%
skimmed milk and 1% BSA at RT on an orbital shaker, the membranes were incubated with the primary
antibodies (mouse anti-HA-tag [clone 16B11, BioLegend, San Diego, CA, USA] at 1:1000 and mouse
anti-VSV-M [clone 23H12, KeraFast, Boston, MA, USA] at 1:2000 dilution in blocking buffer) overnight
at 4 ◦C, washed three times with TBS-T, probed with the secondary antibody (donkey anti-mouse
AlexaFluor800 at 1:10,000 dilution in blocking buffer) for 1 h at RT, washed three times with TBS-T
and twice with TBS, and recorded the results with the Odyssey Infrared Imaging System (LI-COR
biosciences, Lincoln, NE, USA).
3. Results
3.1. Production of Arenavirus GP-Pseudotyped scrVSV∆G-eGFPs in HEK293FT Cells
Snakes with BIBD often harbor more than one S segment [20,21], and an infected snake can
carry differing sets of L and S segments in different tissues [20]. To examine whether, as with
mammarenavruses, reptarenavirus GPC gene defined cell type and species tropism, we generated
pseudotyped forms of the scrVSV∆G-eGFP bearing different reptarenavirus GPs. We selected the
GPs based on phylogenetic analysis (Figure 1) and included representatives of OW (LCMV) and NW
(JUNV) mammarenaviruses and hartmanivirus (HISV-1) as controls.
To assess the expression and processing of reptarenavirus GPCs occurs in mammalian cells,
we transfected HEK293FT cells with plasmids expressing HA-epitope tagged forms of arenavirus
GPCs and assessed their expression by immunoblotting. Reptarenavirus GPCs efficiently expressed in
mammalian cells but processing of GPCs was not very efficient (Figure 2). The observed size variation
between the different GPCs likely reflects differences in both their length and glycosylation. The HA-tag
was located in the C-terminus of GPC and therefore it detected GP2. Reptarenavirus GP2s have a
consistent size of approximately 190 amino acids, slightly smaller than GP2s of mammarenaviruses
and hartmaniviruses [22]. Among the multiple mono- and polyclonal anti-HA antibodies we tested,
all detected GPC, but only one detected processed GPC (i.e., GP2). Processing of reptarenavirus
GPCs produced multiple bands migrating between the 10 and 37 kDa marker lanes (Figure 2A).
Bands migrating between 25 and 37 kDa marker likely represent GP2 species with different degree of
glycosylation. Bands migrating at 10 and 15 kDa may represent products of proteolytic degradation
of the GP2, or polypeptides produced via alternative transcription or translation initiation, or from
leaky scanning. GPCs of hartmani- and mammarenavirus were expressed and processed, as judged by
bands migrating close to the 37 kDa marker, likely corresponding to GP2.
Viruses 2020, 12, 395 6 of 16
Figure 1. A phylogenetic tree based on the amino acid sequences of arenavirus GPCs. The GPCs
included in the study are in red font.
To determine whether the GPCs and processed GP2s trafficked to the plasma membrane in
HEK293FT cells, we compared the migration pattern of cell surface biotinylated proteins and whole
cell lysates in cells transfected with arenavirus GPCs. Immunoblots of cell surface biotinylated proteins
(Figure 2B) showed a similar pattern to that of whole cell lysates (Figure 2A), indicating efficient
transport of the expressed proteins to the plasma membrane. We observed the same protein expression
pattern in HEK293FT cells transfected with all the plasmids required for production of pseudotyped
scrVSV∆G-eGFP (Figure 2C).
We tested the infectivity of pseudotyped scrVSV∆G-eGFP on the boid heart cell line (V/2Hz),
and compared their infectivity to that of the positive, scrVSV∆G-eGFP pseudotyped with VSV G,
and negative, scrVSV∆G-eGFP, controls. The supernatants collected from cells transfected with
arenavirus GPCs containing the pseudotyped scrVSV∆G-eGFP particles were used in subsequent
experiments, further demonstrating that the GPC processing produced particles capable of entering
different cell lines.
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Figure 2. Immunoblots of transfected cells and concentrated VSV pseudotypes. (A) Expression of
arenavirus GPCs in HEK293FT. The proteins separated on SDS-PAGE and transferred onto nitrocellulose
were probed with an anti-HA antibody. (B) Anti-HA immunoblot of biotinylated plasma membrane
proteins from cells transfected with arenavirus GPCs. (C) Anti-HA immunoblot of HEK293FT cells
transfected with arenavirus GPCs at 3 days post VSV inoculation. In A to C, the intact GPCs migrate
at approximately 60–75 kDa and the cleaved GP2s between 10 and 37 kDa, as indicated. Anti-FLAG
antibody served for ABV-1 GPC detection from the same membrane, but due to differences in the
band intensity the anti-FLAG staining is shown as a strip overlaid on top of the anti-HA staining.
M = molecular weight marker (Precision Plus Protein Dual Color Standards, Bio-Rad). Odyssey
Infrared Imaging System (LI-COR) served to record the results.
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3.2. Differences in Tissue and Species Tropism of Reptarenaviruses
We used scrVSV∆G-eGFP pseudotyped with nine reptarena-, one hartmani-, and two mammarenavirus
GPCs to infect a panel of six mammalian and six reptilian cell lines, and used scrVSV∆G-eGFP
pseudotyped with VSV-G (scrVSV∆G-eGFP/VSV-G) as positive control. scrVSV∆G- eGFP pseudotyped
with GPCs of JUNV and LCMV, with known receptors [35,38,56,57], served as additional controls
to assess GP-mediated cell entry into mammalian cells. scrVSV∆G-eGFP/VSV-G efficiently infected
efficiently all mammalian cell lines we tested, ranging from 70% (SK-N-SH) to 97% (BHK-21).
We observed a greater variation in the ability of scrVSV∆G-eGFP/VSV-G to infect reptilian cells,
12% (V/5Lu, boa lung) to 85% (V/1Liv, boa liver (Figure 3A). The negative control scrVSV∆G-eGFP
infected less than 0.1% of cells in all cell lines tested (Figure 3B).
We calculated the infectivity of each pseudotyped scrVSV∆G-eGFP produced on each cell
line based on the dilution used and the number of fluorescent foci (Table 1), which revealed
differences among reptarenavirus GPs in their ability to mediate cell entry. To avoid the confounding
factor related to differences in VSV replication and gene expression among the different cell types,
we normalized the infectivity values for VSVs pseudotyped with arenavirus GPs to those obtained
with scrVSV∆G-eGFP/VSV-G in each cell line (Figure 4).
All the tested arenavirus GPs provided efficient entry into mammalian cells, whereas only JUNV
GP showed preference to a reptilian cell line (V/2Hz, boa heart). Of the reptarenavirus GPs, the one of
CASV-1 very efficiently mediated entry into HEK293FT and V/2Hz cells, whereas other cell lines were
less susceptible to CASV-1 GP-mediated cell entry (Table 1). The tested arenavirus GPs showed low
variation in their ability to provide entry into Vero E6 cells, commonly utilized for virus propagation.
BHK-21 cells were highly permissive to cell entry mediated by GPs of all arenavirus tested except for
that of CASV-1. Similarly, all tested arenavirus GPs provided efficient entry into the SK-N-SH, CHO
and HEK293FT cell lines. A549 cells were also permissive to arenavirus GP bearing pseudotypes.
Intriguingly, only two, UHV-2 and S5, of the reptarenavirus GPs efficiently facilitated entry into
I/1Ki, the boa kidney cell line employed in our earlier studies [15,22,48,50], indicating that factors
other than entry contribute to reptarenavirus cell and tissue tropism. All tested arenavirus GPs,
including those of hartmani- and mammarenaviruses, efficiently mediated entry into the V/2Hz cell
line. The V/5Lu cell line showed low permissiveness for most arenavirus GPs. The low infectivity of
scrVSV∆G-eGFP/VSV-G in V/5Lu cells (Figure 3) may account for the observed results, suggesting
restricted VSV replication and gene expression in this cell line. V/4Br cells exhibited low permissiveness
for all tested arenavirus GPs. Most arenavirus GPs, except CASV-1 and TSMV-2, mediated cell entry
into V/1Liv cells at moderate efficiency, a finding consistent with the observation that hepatocytes
consistently exhibit IB in snakes with BIBD. GPs of UHV-1, UHV-2, ABV-1, and ABV-2 provided low
entry efficiency into python liver cells (VII/1Liv, green tree python). The inability of VII/1Liv cells to
support efficient VSV replication, as suggested by the low number of infected cells observed with
scrVSV∆G-eGFP/VSV-G control (Figure 3), could partially explain this result.
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Figure 3. Control infections on all cell lines with naked VSV (VSV-G0) and VSV pseudotyped with its
own GP (VSV-G). The X-axes represent the different cells lines and the Y-axis the number of infected cells
(left) or the percentage of cells infected (right). The values represent the average of four measurements,
and the error bars show standard deviation. White bars represent mammalian and grey bars reptilian
cell lines. (A) Infection efficiency of VSV-G in mammalian (white bars) and reptilian (grey bars) cell
lines. (B) Infection efficiency of VSV-G0 in mammalian (white bars) and reptilian (grey bars) cell lines.
Opera Phenix high content image screening system served to quantify the infected cells based on eGFP
expression and staining of nuclei with Hoechst 33342.
Table 1. Infectivity of the pseudotyped viruses in mammalian and reptilian cell lines. The infectivity
values are the average of quadruplicates and expressed in 1000 FFFU/mL. For each virus, light red
highlights the cell line with the highest and light blue the cell line(s) with the lowest infectivity.
Mammalian Cells Reptilian Cells
Virus
Type Vero E6 BHK-21 SK-N-NH CHO wt HEK293FT A549 I/1Ki V/2Hz V/5Lu V/4Br V/1Liv VII/2Liv
UHV-1 305.9 905.7 19.5 1112.0 748.3 290.6 74.4 230.4 0.2 0.2 4.5 1.2
UGV-1 539.7 1823.4 50.5 2080.0 1297.0 337.2 175.5 326.3 1.8 2.8 5.4 0.4
UHV-2 617.1 2052.5 55.3 2346.1 2238.7 264.2 1421.6 373.8 2.7 1.8 8.4 1.4
GGV-1 1002.7 3800.7 106.1 6567.7 2700.5 357.8 336.6 480.3 4.0 2.1 8.3 0.3
CASV-1 11.9 107.4 2.1 96.0 2819.3 28.1 352.6 517.6 3.8 0.2 0.1 0.5
ABV-1 667.0 1208.6 27.6 2102.9 1448.9 226.9 283.1 463.0 0.8 4.8 11.5 0.8
ABV-2 869.1 2071.6 90.8 3016.5 1485.3 305.0 218.4 367.6 7.3 2.6 13.1 1.0
TSMV-2 304.9 684.7 79.5 1092.6 1223.6 239.7 69.7 97.3 1.2 0.4 1.9 0.1
S-5 543.8 1389.4 65.6 1909.9 1669.5 303.6 596.8 184.9 7.0 0.2 7.7 0.5
HISV-1 512.4 1655.4 47.3 2309.3 1083.5 338.5 148.2 282.6 1.5 0.5 8.6 0.3
LCMV 439.7 1119.4 66.8 1515.3 1738.0 251.8 158.8 320.8 2.7 2.3 12.3 0.4
JUNV 536.9 1284.5 81.1 1994.6 1570.6 190.7 220.1 451.1 3.1 0.9 9.6 0.1
VSV-G 23000.0 10048.6 514.2 6698.9 7056.7 18668.0 7906.8 1755.5 164.2 1254.9 212.0 628.9
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Figure 4. Infectivity of cell lines by pseudotyped viruses, indicating cell count of GFP positive
cells. The mammalian cell lines are presented by white bars and the reptilian cell lines by grey bars,
the X-axes indicate the individual cell lines and the Y-axes show the permissiveness in relation to VSV-G
pseudotypes, expressed as relative percentage in comparison to the most permissive cell line. The values
represent the average of four measurements, and the error bars show standard deviation. Abbreviations
for the viruses: UHV-1—University of Helsinki Virus-1, UHV-2—University of Helsinki Virus-2,
UGV-1—University of Giessen virus-1, GGV-1—Golden Gate Virus-1, CASV-1—California Academy of
Sciences virus-1, ABV-1—auroa borealis virus-1, ABV-2—aurora borealis virus-2, TSMV-2—tavallinen
suomalainen mies virus-2, S-5—S-5 like segment virus, HISV-1—Haartman Institute snake virus-1,
LCMV—Lymphocytic choriomeningitis virus, JUNV—Junin virus.
4. Discussion
Arenavirus infection at the cellular level is initiated by the interaction of the virus surface GP
with its receptor on the cell surface. A main cellular receptor for LCMV, LASV and several other OW
mammarenaviruses is alpha dystroglycan (α-DG) [38,56], whereas pathogenic NW mammarenaviruses
use the human transferrin receptor-1 (TfR1) for their entry [35], and LUJV, which does not cluster
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with either NW or OW mammarenaviruses, uses neuropilin-2 (NRP2) [46]. The cellular receptors
used by reptarenaviruses and hartmaniviruses are unknown. Reptarenaviruses, and occasionally
hartmaniviruses, are found in snakes with BIBD, and co-infections by multiple reptarenaviruses
appear common [20,21]. Evidence suggest that reptarenaviruses have a very broad tissue tropism,
which indicates that they use a ubiquitously expressed receptor. However, these studies only allowed
identification of the viruses at genus level [13,15]. Our recent data suggest that there is variation in
the distribution of L and S segments between different tissues of an individual infected snake [23].
Herein, we used pseudotyped rscVSV∆G-eGFP to characterize the ability of reptarenavirus GPs to
mediate cell entry into a variety of mammalian and reptilian cell lines. Our study included the GPs of
nine reptarenaviruses and one hartmanivirus (HISV-1), the GPs of two mammarenaviruses (LCMV
and JUNV) served as controls with known receptor usage (Figure 1). We used rscVSV∆G-eGFP and
rscVSV∆G-eGFP/VSV-G as controls to evaluate the assay background and the ability of VSV to replicate
in different cell lines.
Mammarenavirus GPC processing into SSP, GP1 and GP2 is required for the GP2-mediated
pH-dependent fusion event required to release the viral ribonucleoprotein (vRNP) into the cytoplasm
of the host cell, where vRNP directs replication and transcription of the viral genome [58–60]. Therefore,
we evaluated processing of various arenavirus GPCs in mammalian HEK293FT cell line. We used
C-terminal HA-tagged GPCs to facilitate detection of GPC and GP2. We tested several poly- and
monoclonal anti-HA antibodies, and found that only one of them efficiently detected both GPC and
GP2. We observed processing of all GPCs tested in HEK293FT, but at relative low efficiency (Figure 2A).
Cells transfected with reptarenavirus GPCs showed often four bands with varying intensity around the
10–37 kDa region (Figure 2A), with bands migrating at approximately 25 and 37 kDa likely representing
GP2. The prominent bands at approximately 10 and 15 kDa may correspond to GP2 degradation
fragments, or products from leaky ribosome scanning or alternate translation initiation sites. The
results from biotinylation studies indicate that the expressed GPs are efficiently trafficked to the plasma
membrane (Figure 2B). The migration pattern of biotinylated proteins looked similar to that observed
when analyzing proteins in whole cell lysates, indicating that unprocessed GPCs reached the plasma
membrane. We confirmed the same pattern of GPC expression and processing in cells transfected
with all the plasmids required for production of pseudotyped rscVSV∆G-eGFP (Figure 2C), but the
amount of GP2s appeared to be lower (when comparing the intensities of the GPC and GP2 bands)
under these conditions. We also tested the ability of I/1Ki (boid kidney) cells to mediate production of
VSV pseudotyped with arenavirus GPs and found that the particles produced in both HEK293FT and
I/1Ki had a similar ability to infect mammalian and reptilian cell lines.
Most of our primary cell lines originated from euthanized juvenile three to 21 day-old Boa
constrictor imperator snakes. We noted a variety of cell subpopulations as judged by cell pleomorphism
in the initial passages of the cell lines (up to 15 passages). At later passages (from 15 to 30) the cultures
begun to demonstrate monomorphous cells, which we interpret as a narrow population of stable cell
lines (ages from 5 to 15 years, and at passages 45–130) derived from the particular organ. According
to our immunohistological analyses we characterize them as follows: I/1KI, epithelial (tubular) cells;
V/2Hz, cardiomyocytes; V/5Lu, (vascular) smooth muscle cells; V/4Br, (vascular) smooth muscle
cells; and V/1Liv, hepatic stellate cells; the VII/1Liv remains uncharacterized. The ability of different
reptarenavirus GPs to mediate entry into reptilian cells did not vary considerably (Figure 4 and Table 1),
with the exception of the CASV-1 GP that showed much higher efficiency in HEK293FT and V/2Hz cell
lines. These differences could reflect that CASV-1 originates from a Corallus annulatus [13], whereas
other viruses infect boa constrictors. UHV-2 and S5-like GPs showed the highest entry efficiency in
I/1Ki cells, the cell line which we routinely employ for the isolation of reptarenaviruses [15,20,22,23,48].
Interestingly, HISV-1 and UHV-2, originally isolated together [20,22], showed a similar preference for
mammalian cell lines but significantly differed in their ability to infect the boid kidney (I/1Ki) cells.
The low entry efficiency of pseudotypes with reptarenavirus GPs into I/1Ki indicates that entry is
not the only factor defining the cell and tissue tropism of these viruses. Thus, UGV-1 and HISV-1
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reach very high titers in I/1Ki [22] though our results showed low efficiency of cell entry mediated
by these virus GPs. Horizontal transmission of reptarenavirus infection has been documented [21],
suggesting potential aerosol transmission. Our results showed that most reptarenavirus GPs could
mediate entry into boa (V/5Lu) and human (A549) lung cells (Figure 4 and Table 1). The lower VSV
replication efficiency in V/5Lu (Figure 3) could have contributed to the observed lower entry rate in
this cell line. Additionally, the cell line might not represent the optimal target cells of reptarenaviruses.
In BIBD, reptarenavirus infection is often associated with CNS signs, and we originally identified
TSMV-2 in the brain of a snake with multiple reptarenavirus L and S segments in the blood [23].
Curiously, the boa brain cell line (V/4Br) proved to be poorly permissive for pseudotypes bearing
arenavirus GPs, especially for those of UHV-1, HISV-1, CASV-1, TSMV-2, and S5-like (Figure 4 and
Table 1). While this finding is rather surprising, it could reflect the fact that the reptilian cell lines
included in the study represent quite homogenic cell populations that derive from spontaneously
immortalized cultures generated from homogenates of different tissues. Given the limitation of
our study, the results do not rule out the possibility of efficient viral replication in the brain nor in
this particular cell line, since reptarenavirus IBs are generally frequent in neurons in the brain of
boas [13–15,23]. The reptarenavirus GPs differentially mediated entry into boa (V/1Liv) and python
(VII/1Liv) liver cells; while the boa cells were rather permissive, the python cells appeared to be
non-permissive. In snakes with BIBD, the liver cells often exhibit abundant IBs [11,13,15,61], and thus
the result could indicate a species tropism. However, as discussed above, several other factors could
contribute to this observation. When characterizing HISV-1 we speculated that cell-to-cell transmission
plays a role in its life cycle, due to observed alterations at the plasma membrane of HISV-1 infected
cells [22]. Cell-to-cell transmission, reported for several viruses [62,63], would also help to explain some
of the peculiar results (e.g., low entry efficiency in reptilian cell lines known to support reptarenavirus
infection) of the present study using pseudotyped VSV particles.
Mammarenavirus GPs efficiently mediated entry into both mammalian and reptilian cell lines.
One could speculate that the entry of mammarenaviruses into snake cells relies on receptor homologies
between reptiles and mammals. Basic Local Alignment Search Tool (BLAST) search at NCBI shows
that the amino acid identity between human and python (the genes for B. constrictor are not available)
α-DG is approximately 74%, while the identity between human and python TfR1 is 51%. It is plausible
that mammarenavirus entry into snake cells may occur via the corresponding receptor orthologues.
JUNV entry efficiency varies between the specific TfR1 species [64], being highest with the TfR1 of
JUNV’s reservoir host (Calomys musculinus) [36]. JUNV enters human cells through TfR1, and e.g.,
the TfR1 orthologue of the cat (Felis catus) can mediate JUNV entry while the TfR1 orthologues of mouse
and rat do not support its entry [36]. Several OW mammarenaviruses use α-DG as a main receptor
for cell entry [38]. However, these OW mammarenaviruses can use additional cell surface receptors
and cofactors for efficient entry [65,66]. Both LCMV and JUNV GPs showed similar preferences for
mammalian and reptilian cell cultures in our study. The fact that we used native cell lines as opposed
to cell lines overexpressing TfR1 and α-DG could be compatible with both TfR1 and α-DG dependent
and independent entry. The observed differences in the entry efficiencies of the tested arenavirus GPs
provides a good starting point for future studies addressing the receptor preference of reptarenaviruses.
5. Conclusions
Herein, we studied the entry abilities of arenaviruses in a spectrum of cultured mammalian and
reptilian cell lines. We think that our results are indicative of receptor abundance in the tested cell lines,
and thus provide preliminary data for further studies of receptor usage and cell tropism with isolated
viruses. The observed differences in the “GP-driven” tropism need to be revisited using isolated
reptarena- and hartmaniviruses, since factors other than entry significantly contribute to the tissue and
cell tropism. The large swarm of L and S segments in BIBD-infected snakes may have an impact on the
receptor-induced restriction of tissue tropism. The python liver cell line, VII/1Liv, which showed to be
rather impermeable to the VSV pseudotypes with arenavirus GPs, could serve in future transfection
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studies to assess the receptor usage of reptarenaviruses. The findings that reptarenavirus GPs efficiently
mediate entry into mammalian cell lines and mammarenavirus GPs to reptilian cell lines could indicate
an underlying cross-species transmission potential of arenaviruses; however, our earlier study showed
mammalian body temperature to be suboptimal for reptarenavirus replication [48].
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